Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.


TSXV:COV - Post by User

Post by bronkrdron Oct 17, 2022 11:09am
105 Views
Post# 35028930

Features and Benefits is Outstanding!

Features and Benefits is Outstanding!
  • Infection rates steadily declined over the course of the project, reaching 0 infections after 1 year
  • The transparency of SurgiClear reduced the number of dressing changes, in turn reducing exposure and manipulation of the healing wound
  • Application of SurgiClear was successful across a wide range of age groups and incision types
  • There have been no adverse events or cases of compromised skin integrity
  • The low-profile transparent design of the SurgiClear dressing was well received by patients' parents and caregivers, empowering them to monitor for signs of complications
  • Use of SurgiClear conserved nursing time

<< Previous
Bullboard Posts
Next >>